Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Brain delivery systems via mechanism independent of receptor-mediated endocytosis and adsorptive-mediated endocytosis.

Thomsen LB, Lichota J, Eskehave TN, Linemann T, Mortensen JH, du Jardin KG, Moos T.

Curr Pharm Biotechnol. 2012 Sep;13(12):2349-54. Review.

PMID:
23016641
3.

Adsorptive-mediated brain delivery systems.

Lu W.

Curr Pharm Biotechnol. 2012 Sep;13(12):2340-8. Review.

PMID:
23016640
4.

Drug delivery to brain via the blood-brain barrier.

Scherrmann JM.

Vascul Pharmacol. 2002 Jun;38(6):349-54. Review.

PMID:
12529929
5.

Macromolecular drug transport into the brain using targeted therapy.

Lichota J, Skjørringe T, Thomsen LB, Moos T.

J Neurochem. 2010 Apr;113(1):1-13. doi: 10.1111/j.1471-4159.2009.06544.x. Epub 2009 Dec 14. Review.

6.

Transport of drugs across the blood-brain barrier by nanoparticles.

Wohlfart S, Gelperina S, Kreuter J.

J Control Release. 2012 Jul 20;161(2):264-73. doi: 10.1016/j.jconrel.2011.08.017. Epub 2011 Aug 18. Review.

PMID:
21872624
7.

Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.

Smith MW, Gumbleton M.

J Drug Target. 2006 May;14(4):191-214. Review.

PMID:
16777679
8.

Nanoparticles as novel carrier for brain delivery: a review.

Agarwal A, Lariya N, Saraogi G, Dubey N, Agrawal H, Agrawal GP.

Curr Pharm Des. 2009;15(8):917-25. Review.

PMID:
19275654
9.

Combinatorial approaches for the identification of brain drug delivery targets.

Stutz CC, Zhang X, Shusta EV.

Curr Pharm Des. 2014;20(10):1564-76. Review.

PMID:
23789958
10.

Targeting the brain: advances in drug delivery.

Blumling Iii JP, Silva GA.

Curr Pharm Biotechnol. 2012 Sep;13(12):2417-26. Review.

PMID:
23016646
11.

Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.

Kreuter J.

J Nanosci Nanotechnol. 2004 May;4(5):484-8. Review.

PMID:
15503433
12.

Vector-mediated drug delivery to the brain.

Temsamani J, Rousselle C, Rees AR, Scherrmann JM.

Expert Opin Biol Ther. 2001 Sep;1(5):773-82. Review.

PMID:
11728213
13.

Prodrug based optimal drug delivery via membrane transporter/receptor.

Yang C, Tirucherai GS, Mitra AK.

Expert Opin Biol Ther. 2001 Mar;1(2):159-75. Review.

PMID:
11727527
14.

Penetratin-functionalized PEG-PLA nanoparticles for brain drug delivery.

Xia H, Gao X, Gu G, Liu Z, Hu Q, Tu Y, Song Q, Yao L, Pang Z, Jiang X, Chen J, Chen H.

Int J Pharm. 2012 Oct 15;436(1-2):840-50. doi: 10.1016/j.ijpharm.2012.07.029. Epub 2012 Jul 24.

PMID:
22841849
15.

Targeted drug delivery across the blood brain barrier in Alzheimer's disease.

Rocha S.

Curr Pharm Des. 2013;19(37):6635-46. Review.

PMID:
23621533
16.

Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway.

Qian ZM, Li H, Sun H, Ho K.

Pharmacol Rev. 2002 Dec;54(4):561-87. Review.

17.

Receptor-mediated therapeutic transport across the blood-brain barrier.

Wang YY, Lui PC, Li JY.

Immunotherapy. 2009 Nov;1(6):983-93. doi: 10.2217/imt.09.75. Review.

PMID:
20635914
18.

Blood-brain barrier delivery.

Pardridge WM.

Drug Discov Today. 2007 Jan;12(1-2):54-61. Epub 2006 Nov 13. Review.

PMID:
17198973
19.

Perspectives on brain-targeting drug delivery systems.

Guo L, Ren J, Jiang X.

Curr Pharm Biotechnol. 2012 Sep;13(12):2310-8. Review.

PMID:
23016637
20.

Strategy for effective brain drug delivery.

Alam MI, Beg S, Samad A, Baboota S, Kohli K, Ali J, Ahuja A, Akbar M.

Eur J Pharm Sci. 2010 Aug 11;40(5):385-403. doi: 10.1016/j.ejps.2010.05.003. Epub 2010 May 16. Review.

PMID:
20497904

Supplemental Content

Support Center